Advertisement

Biden advisers to meet with coronavirus vaccine firms as Trump stalls transition

Click to play video: 'U.S. election: Top Biden aide says government must approve transition this week'
U.S. election: Top Biden aide says government must approve transition this week
WATCH: U.S. election: Top Biden aide says government must approve transition this week – Nov 15, 2020

Joe Biden’s scientific advisers will meet with vaccine makers in coming days as the presidential transition remains stalled because of President Donald Trump’s refusal to acknowledge that he lost the election. That delayed handoff to the next administration is especially problematic during a public health crisis, the government’s top infectious disease expert said.

“Of course it would be better if we could start working with them,” said Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases who has been through many presidential transitions during 36 years of government service. He likened the process to runners passing on the baton in a relay race. “You don’t want to stop, he said.

The president-elect’s outreach to the vaccine manufacturers comes as the coronavirus pandemic in the United States has entered perhaps its most dangerous phase. The seven-day rolling average for new daily cases stood at 145,400 on Saturday, according to data from Johns Hopkins University. That means the U.S. is adding about 1 million new cases a week, and deaths averaged 820 a day, a 33 per cent increase in just two weeks.

Story continues below advertisement

“We’re going to start those consultations this week” said Biden’s chief of staff, Ron Klain, citing Pfizer and other pharmaceutical companies.

Receive the latest medical news and health information delivered to you every Sunday.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

Pfizer’s announcement that preliminary data indicate its vaccine is 90 per cent effective lifted financial markets last week and gave many people worldwide hope that an end to the pandemic will be coming.

Around the country, hospitals report that doctors and nurses are being stretched to cope with rising numbers of hospitalized COVID-19 patients requiring special care. In some communities, hospitals have started limiting elective procedures in order to conserve resources.

Fauci stressed it won’t be like flipping a switch to return to normal life when the first vaccine doses become available for high-risk groups, most likely next month. He said Americans will have to keep up preventive measures such as wearing masks, observing social distancing and frequently washing their hands well into next year.

Click to play video: 'Pfizer-BioNTech coronavirus vaccine: The refrigeration problem no one is talking about'
Pfizer-BioNTech coronavirus vaccine: The refrigeration problem no one is talking about

“Everybody is sensitive to what we call `COVID fatigue,’ ” Fauci said. “But we’ve got to hang in there. We’ve got to hang together .. .because we can make it turn around.”

Story continues below advertisement

Fauci has been target of frequent complaints from Trump, and the president’s supporters have called for him to be fired.

Other vaccine makers are also in the final phase of testing their formulations, and Fauci said he expects those vaccines will also be highly effective.

The government has launched a program called “Operation Warp Speed,” backed by the White House, to quickly manufacture and distribute tens of millions of doses of vaccines. The shots will be free to Americans, and the goal is to have most people vaccinated by about this time next year. Many people will need two doses.

Initial access to the vaccine will be limited to high-priority groups such as hospital and nursing home workers.

Fauci was on CNN’s “State of the Union” and Klain appeared on NBC’s “Meet the Press.”

Sponsored content

AdChoices